Patients with mast cell disorders can experience symptoms affecting many different parts of the body, including itching, flushing, hives, abdominal discomfort, diarrhea, nasal symptoms, headaches, and episodes of lightheadedness or rapid heartbeat. Treatment often focuses on blocking the substances released by mast cells and reducing their effects on the body.
One medication sometimes used as part of this approach is ketotifen.
What Is Ketotifen?
Ketotifen is an antihistamine with mast cell–stabilizing properties. It blocks histamine at the H1 receptor and may also help reduce the release of inflammatory mediators from mast cells.
Because mast cells release histamine and other chemicals during activation, ketotifen may be considered for certain patients with conditions involving excessive or inappropriate mast cell activation.
These may include:
- Mast cell activation syndrome (MCAS)
- Systemic mastocytosis
- Cutaneous mastocytosis
- Chronic urticaria or recurrent hives in selected patients
- Other allergic disorders associated with histamine-mediated symptoms
Ketotifen does not eliminate mast cells and is not considered a cure for mast cell disease. Instead, its goal is symptom control.
How Does Ketotifen Work?
Ketotifen has two potentially useful actions.
1. H1 antihistamine activity
Histamine released by mast cells can contribute to symptoms such as:
- Itching
- Hives
- Flushing
- Nasal congestion or runny nose
- Watery or itchy eyes
By blocking the H1 histamine receptor, ketotifen can reduce some of these histamine-mediated symptoms.
2. Mast cell–stabilizing effects
Ketotifen is also described as having mast cell–stabilizing activity. This is one reason it has attracted interest in patients with mast cell activation disorders.
However, the clinical evidence for ketotifen specifically in mast cell activation syndrome is limited, and treatment of MCAS is often individualized based on symptoms, response to therapy, and the presence of other conditions.
What Symptoms May Ketotifen Help?
The response to ketotifen varies considerably from one person to another.
Depending on the patient and the underlying disorder, physicians may consider it when symptoms include:
- Recurrent itching
- Hives
- Flushing
- Gastrointestinal symptoms
- Nasal or eye allergy symptoms
- Persistent histamine-related symptoms despite other antihistamines
Some patients with mast cell disorders require several medications that target different mast cell mediators rather than relying on a single medication.
Where Does Ketotifen Fit Into Mast Cell Treatment?
Treatment for mast cell disease depends heavily on the exact diagnosis.
A physician may use combinations of medications such as:
- H1 antihistamines for itching, hives, and flushing
- H2 antihistamines for certain gastrointestinal and histamine-related symptoms
- Mast cell–targeted medications, including cromolyn in selected patients
- Leukotriene-modifying medications in appropriate cases
- Additional therapies based on the patient’s specific symptoms and diagnosis
Ketotifen can sometimes serve both as an H1 antihistamine and as a medication with mast cell–stabilizing properties.
It should not automatically replace other medications that are already controlling symptoms successfully.
Ketotifen vs. Cromolyn
Patients with MCAS frequently ask about the difference between ketotifen and cromolyn sodium.
Both medications are discussed as mast cell–stabilizing therapies, but they are not interchangeable.
Cromolyn is frequently considered when gastrointestinal symptoms are prominent, while ketotifen also has direct antihistamine activity and may be useful when symptoms such as itching, hives, or flushing are significant.
Some patients may receive both medications under the supervision of a physician.
The choice should be based on the patient’s symptoms, other medications, medical history, and previous treatment response.
How Quickly Does Ketotifen Work?
Ketotifen should not necessarily be judged after only one or two doses. Its antihistamine effects may be noticed sooner, while determining whether it provides meaningful overall improvement in a mast cell disorder may require a longer period of observation.
Response varies substantially among patients.
Patients should follow the treatment plan established by their physician rather than increasing the medication on their own because symptoms have not immediately improved.
What Are the Side Effects of Ketotifen?
One of the most important potential side effects is drowsiness or sedation, particularly when treatment is first started.
Other possible side effects can include:
- Fatigue
- Dizziness
- Dry mouth
- Increased appetite
- Weight gain
Because it may cause sedation, patients should understand how ketotifen affects them before driving or performing activities requiring full alertness.
Alcohol, sedating medications, sleep medications, and other drugs that cause drowsiness may increase sedation. A physician or pharmacist should review potential interactions with the patient’s existing medications.
Is Ketotifen Available in the United States?
The availability of ketotifen depends on the formulation and country.
Ketotifen is familiar to many Americans as an antihistamine eye drop used for allergic conjunctivitis. Oral ketotifen availability is different and may require special prescribing or preparation depending on location.
Patients should not substitute ketotifen eye drops for oral ketotifen or use one formulation in a way it was not intended to be used.
Is Ketotifen a Treatment for MCAS?
Ketotifen may be used as part of a treatment strategy for some patients diagnosed with mast cell activation syndrome, but MCAS treatment is more complicated than simply prescribing a mast cell stabilizer.
Symptoms attributed to mast cell activation can overlap with many other medical conditions. A careful evaluation is important before assuming that symptoms are caused by MCAS.
Treatment is usually directed toward:
- Identifying reproducible triggers when possible
- Blocking mast cell mediators
- Controlling individual symptoms
- Treating associated allergic disorders
- Evaluating for other explanations for the patient’s symptoms
No single medication works for every patient.
Ketotifen Is Not a Substitute for Epinephrine
Patients with mast cell disorders may also be at risk for severe allergic reactions.
Ketotifen is not a rescue treatment for anaphylaxis.
If a patient has been prescribed an epinephrine autoinjector, ketotifen does not replace it. Symptoms suggesting anaphylaxis—such as difficulty breathing, throat tightness, significant tongue or throat swelling, collapse, or rapidly progressing symptoms involving multiple organ systems—require immediate emergency treatment according to the patient’s prescribed anaphylaxis plan.
Who Should Discuss Ketotifen With an Allergist?
Ketotifen may be worth discussing when a patient has persistent symptoms thought to involve mast cell mediators despite an appropriate initial treatment strategy.
Before prescribing it, the physician should review:
- The suspected or confirmed mast cell diagnosis
- Current antihistamines
- Other prescription and over-the-counter medications
- Previous medication reactions
- Degree of sedation from other antihistamines
- Pregnancy or breastfeeding status when applicable
- Other medical conditions that could influence treatment
The Bottom Line
Ketotifen is an H1 antihistamine with mast cell–stabilizing properties that is sometimes incorporated into the treatment of mast cell–mediated disorders.
For selected patients with MCAS, mastocytosis, or other histamine-mediated conditions, it may help control symptoms such as itching, hives, flushing, or gastrointestinal complaints. However, the evidence for ketotifen in MCAS remains limited, responses vary among patients, and it should be viewed as one possible component of a broader treatment plan rather than a cure.
If you have symptoms that you believe may be caused by mast cell activation, an evaluation by an allergist or another physician experienced in mast cell disorders can help determine whether additional testing or treatment—including ketotifen—is appropriate.
MCAS Treatment: Medication Options for Mast Cell Activation Syndrome